From Medscape Rheumatology

Medscape Coverage from the

European League Against Rheumatism (EULAR) Congress 2017

June 14 - 17, 2017; Madrid, Spain

June 14 - 17, 2017 Madrid, Spain

EULAR Real-World Tradeoffs of Biosimilars in Spotlight at EULAR Head-to-head drug comparisons and clinical trials designed to answer the toughest questions in rheumatology will be featured at the upcoming European League Against Rheumatism (EULAR) Congress.
Medscape Medical News, June 12, 2017

Conference News

EULAR Supreme Court Ruling on Biosimilars Will Lower Drug Costs
Medscape Medical News, August 17, 2017
EULAR Nonmedical Biosimilar Switch Results Surprise Investigators
Medscape Medical News, June 30, 2017
EULAR One in 10 in Rheumatic Pain Switch Back From a Biosimilar
Medscape Medical News, June 22, 2017
EULAR Tocilizumab Triumphs in Methotrexate Combo for RA
Medscape Medical News, June 20, 2017

EULAR Biologics Comparison in Rheumatoid Arthritis Surprises
Medscape Medical News, June 20, 2017
EULAR Biologic-Naive Respond Better to TNF Combination in RA
Medscape Medical News, June 16, 2017
EULAR New Biosimilar for Adalimumab in Rheumatoid Arthritis
Medscape Medical News, June 15, 2017
EULAR Real-World Tradeoffs of Biosimilars in Spotlight at EULAR
Medscape Medical News, June 12, 2017

Popular News From EULAR 2016

Impact of Osteoarthritis Underrated by Rheumatologists Rheumatologists are more likely to underestimate the impact of osteoarthritis than rheumatoid arthritis, even though patients with osteoarthritis often have more pain and a greater burden of disease.
Medscape Medical News, Jun 8, 2016
Single Rituximab Injection Delays RA in High-Risk Patients A single infusion of the anti-CD20 antibody rituximab, intended to deplete the B-cell population, delays the onset of rheumatoid arthritis in high-risk patients, results from the PRAIRI study suggest.
Medscape Medical News, Jun 17, 2016
Inflammatory Arthritis Stable After Switch to Biosimilar The switch to an infliximab biosimilar was not associated with any change in disease activity or worsening of flares, at least in the short term, new research shows.
Medscape Medical News, Jun 13, 2016

Medscape Rheumatology© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Previous Coverage

Related Resources